Plain-English translation of NCT05830669 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing remote ischemic preconditioning, a technique that briefly restricts blood flow to your upper arm to help protect your kidneys. Sepsis is a life-threatening condition that can severely damage the kidneys, and currently there are no proven medications to prevent this damage. Researchers believe that this non-invasive arm technique might trigger your body's natural protective mechanisms to shield your kidneys from harm.
Kidney damage is one of the most serious complications in patients with sepsis in the intensive care unit, and there are currently no effective preventive treatments available. This trial aims to test whether this simple, low-risk technique can activate your body's built-in defense systems to protect your kidneys before serious damage occurs.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the actual blood flow technique or a sham (placebo) version. The procedure involves placing a blood pressure cuff on your upper arm: the active treatment uses three cycles of 5-minute blood flow restriction (or two cycles of 10 minutes if needed), while the placebo group receives the same procedure without actual restriction. The technique takes place once during your ICU stay, and researchers will monitor your kidney function through blood tests over the following days to see if the treatment helps prevent kidney damage.
AI-generated summary from trial data · Sep 1, 2026 · Not medical advice
Germany